Deep brain stimulation (DBS) is a neurosurgical procedure that allows targeted circuit-based
neuromodulation. DBS is a standard of care in Parkinson disease, essential tremor and …

Three neuromodulation therapies have been appropriately tested and approved in refractory
focal epilepsies: vagus nerve stimulation (VNS), deep brain stimulation of the anterior …

Epilepsy is one of the most common serious brain conditions, affecting over 70 million
people worldwide. Its incidence has a bimodal distribution with the highest risk in infants and …

Several studies have illustrated that transcutaneous vagus nerve stimulation (tVNS) can
elicit therapeutic effects that are similar to those produced by its invasive counterpart, vagus …

Three decades after its introduction as an adjuvant therapeutic option in the management of
selective drug-resistant epilepsy cases (DRE), vagus nerve stimulation (VNS) retains …

The objective of this clinical practice guideline (CPG) is to provide recommendations for
healthcare personnel working with patients with epilepsy, on the use of wearable devices for …

Brain diseases, including neurodegenerative, cerebrovascular and neuropsychiatric
diseases, have posed a deleterious threat to human health and brought a great burden to …

Abstract Machine learning (ML) is increasingly recognized as a useful tool in healthcare
applications, including epilepsy. One of the most important applications of ML in epilepsy is …

Approximately 50 million people worldwide suffer from epilepsy, and approximately 30% to
40% of these persons have seizures that are refractory to treatment with antiepileptic …

Epilepsy affects almost 1% of the population and most of the approximately 20–30% of
patients with refractory epilepsy have one or more seizures per month. Seizure detection …